Geopolitics Alpha

8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)

Published . Updated .

Key takeaways

  • 8-K - InMed Pharmaceuticals filed an 8-K with the SEC on Nov 16 (a notice of a material company event).
  • Exposed: INM, XLV, XBI, LLY, JNJ
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - InMed Pharmaceuticals Inc.(0001728328) (Filer)MTRIGEOPOLITICS ALPHA

8-K - InMed Pharmaceuticals filed an 8-K with the SEC on Nov 16 (a notice of a material company event).

Directly affected

  • MTRI InMed Pharmaceuticals

    Named in this report.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
MTRI—-12.64%baseafter closeafter closeafter closeafter close
XLV-0.28%+0.04%baseafter closeafter closeafter closeafter close
XBI+4.20%+3.78%baseafter closeafter closeafter closeafter close
LLY-2.25%-0.49%baseafter closeafter closeafter closeafter close
JNJ-1.35%-1.97%baseafter closeafter closeafter closeafter close
PFE+1.19%+1.90%baseafter closeafter closeafter closeafter close
MRK+0.65%-0.38%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-11-16 AccNo: 0001193125-26-462017 Size: 750 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Source: sec-edgar

Price since this story was published: InMed Pharmaceuticals (INM)

CompanyWhenMoveStatus
Johnson & Johnson (JNJ)three days earlier-1.97%final price
Johnson & Johnson (JNJ)five days earlier-1.35%final price
Eli Lilly (LLY)three days earlier-0.49%final price
Eli Lilly (LLY)five days earlier-2.25%final price
Merck (MRK)three days earlier-0.38%final price
Merck (MRK)five days earlier+0.65%final price
MTRIthree days earlier-12.64%final price
Pfizer (PFE)three days earlier+1.90%final price
Pfizer (PFE)five days earlier+1.19%final price
Spdr Series Trust (XBI)three days earlier+3.78%final price
Spdr Series Trust (XBI)five days earlier+4.20%final price
Select Sector Spdr Tr (XLV)three days earlier+0.04%final price
Select Sector Spdr Tr (XLV)five days earlier-0.28%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

Who gains and who loses around InMed Pharmaceuticals (INM)

Companies mentioned with this story

  • INM InMed Pharmaceuticals

    In “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer),” InMed Pharmaceuticals (INM) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> INM

  • XLV Select Sector Spdr Tr

    For “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story

  • XBI Spdr Series Trust

    For “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer),” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story

  • LLY Eli Lilly

    For “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer),” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

  • JNJ Johnson & Johnson

    For “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer),” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

  • PFE Pfizer

    In “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer),” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

  • MRK Merck

    In “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer),” Merck (MRK) is linked, with no stored direction, medium confidence. Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharmaceutical” (pharma and health) in this story

How “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)” reaches InMed Pharmaceuticals (INM)

On 16 Nov 2026, “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)” is the story that connects InMed Pharmaceuticals (INM) to this story.

For InMed Pharmaceuticals (INM), the reason on file says SEC 8-K filing -> direct issuer disclosure -> INM

Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharmaceutical” (pharma and health) in this story

Dates in the story, and the InMed Pharmaceuticals (INM) price range

INM traded between 1.68 and 15.41 across 4 sessions. The latest close on file is 13.95.

How solid “8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)” looks

46 out of 100

“8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.